U.S. Markets closed

Aesthetic Medical International Holdings Group Limited (AIH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.42-0.09 (-1.63%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.07
Open5.95
Bid5.51 x 1100
Ask5.75 x 900
Day's Range5.42 - 5.99
52 Week Range3.81 - 9.78
Volume192,484
Avg. Volume206,800
Market Cap127.982M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateApr 20, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.56
  • Aesthetic Medical International Holdings Group Limited Announces Changes in its Committee Composition
    GlobeNewswire

    Aesthetic Medical International Holdings Group Limited Announces Changes in its Committee Composition

    Shenzhen, China, March 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that Mr. Tsang Eric Chi Wai has resigned from the audit committee (the “Audit Committee”), the compensation committee (the “Compensation Committee”) and the nominating committee (the “Nominating Committee”) of the Company’s board of directors (the “Board”) while remaining as a director on the Board; Mr. Xue Hongwei has resigned as the chair of the Nominating Committee while remaining as a member of the Nominating Committee; and Mr. Lu Feng has resigned as the chair of the Compensation Committee while remaining as a member of the Compensation Committee and as a member of the Nominating Committee. Their resignations from these committees did not result from any disagreement with the Company. To fill the vacancies, Dr. Zhou Pengwu, the chairman of the Board, will join the Nominating Committee as its chair, and Ms. Cathy Peng, an incumbent director, will join the Audit Committee and the Nominating Committee as a member and the Compensation Committee as its chairwoman. About Aesthetic Medical International Holdings Group Limited AIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, with presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third-party industry consultant, AIH was the third largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: https://ir.aihgroup.net/. Safe Harbor Statement This press release contains “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law. Investor Relations Contact For investor and media inquiries, please contact: Aesthetic Medical International Holdings Group Limited Email: ir@pengai.com.cn Ascent Investor Relations LLC Ms. Tina Xiao Tel: (917) 609-0333 Email: tina.xiao@ascent-ir.com

  • Aesthetic Medical International Holdings Group Limited to Host Fourth Quarter and Fiscal Year 2020 Earnings Conference Call at 8:00 am ET on April 20, 2021
    GlobeNewswire

    Aesthetic Medical International Holdings Group Limited to Host Fourth Quarter and Fiscal Year 2020 Earnings Conference Call at 8:00 am ET on April 20, 2021

    Shenzhen, China, March 29, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announces that the Company will host its earnings conference call on Tuesday, April 20, 2021 at 8:00 am Eastern Time (5:00 am Pacific Time/ 8:00 pm Beijing Time) to discuss the Company’s financial results of the fourth quarter and fiscal year ended December 31, 2020. To attend this earnings conference call, please use the information below for either dial-in access or webcast access. When prompted, please reference “Aesthetic Medical International Holdings Group Limited” Conference CallDate:April 20, 2021Time:8:00 am ET, U.S.International Toll Free:United States: +1 888-346-8982 Canada: +1 855-669-9657 Mainland China: +86 400-120-1203 Hong Kong: +852 800-905-945International:International: +1 412-902-4272Conference ID:Aesthetic Medical International Holdings Group Limited Please dial in at least 15 minutes before the commencement of the call to ensure timely participation. For those unable to participate, an audio replay of the conference call will be available from approximately one hour after the end of the live call until April 27, 2021. The dial-in for the replay is +1 877-344-7529 within the United States or +1 412-317-0088 internationally. The replay access code is 10153394. A live and archived webcast of the call will also be available on AIH's website at: https://ir.aihgroup.net/. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. About Aesthetic Medical International Holdings Group Limited AIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: https://ir.aihgroup.net/. Investor Relations ContactFor investor and media inquiries, please contact:Aesthetic Medical International Holdings Group LimitedEmail: ir@pengai.com.cn Ascent Investor Relations LLCMs. Tina XiaoTel: (917) 609-0333Email: tina.xiao@ascent-ir.com

  • Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China
    PR Newswire

    Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China

    Aesthetic Medical International Holdings Group Limited (the "Company" or "AIH", Nasdaq: AIH), a leading provider of aesthetic medical services in China, and Forbes China have jointly released the Chinese Aesthetic Treatment Industry White Paper 2020 (the "White Paper"), the first white paper on the aesthetic treatment industry in China.